Estimating Influenza Vaccine Efficacy From Challenge and Community-based Study Data
暂无分享,去创建一个
[1] A. Langworthy,et al. An influenza simulation model for immunization studies. , 1976, American journal of epidemiology.
[2] B. Murphy,et al. ADVANTAGE OF LIVE ATTENUATED COLD-ADAPTED INFLUENZA A VIRUS OVER INACTIVATED VACCINE FOR A/WASHINGTON/80 (H3N2) WILD-TYPE VIRUS INFECTION , 1984, The Lancet.
[3] B. Murphy,et al. Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine , 1986, Journal of clinical microbiology.
[4] B. Murphy,et al. Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults. , 1988, The Journal of infectious diseases.
[5] B. Murphy,et al. Evaluation of the infectivity, immunogenicity, and efficacy of live cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteers. , 1990, The Journal of infectious diseases.
[6] M E Halloran,et al. Epidemiologic effects of vaccines with complex direct effects in an age-structured population. , 1994, Mathematical biosciences.
[7] F. Hayden,et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. , 1998, The New England journal of medicine.
[8] M E Halloran,et al. Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations. , 1998, Statistics in medicine.
[9] R. Betts,et al. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. , 1999, Vaccine.
[10] M. Halloran,et al. Design and interpretation of vaccine field studies. , 1999, Epidemiologic reviews.
[11] Lihan K. Yan,et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. , 2000, The Journal of infectious diseases.
[12] Lihan K. Yan,et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. , 2000, The Journal of pediatrics.
[13] M E Halloran,et al. Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control. , 2000, Vaccine.
[14] M Elizabeth Halloran,et al. Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] M Elizabeth Halloran,et al. Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness. , 2003, Vaccine.
[16] H. Chu,et al. Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures. , 2003, American journal of epidemiology.
[17] C P Farrington,et al. On vaccine efficacy and reproduction numbers. , 2003, Mathematical biosciences.
[18] I. Longini,et al. The critical vaccination fraction for heterogeneous epidemic models. , 2003, Mathematical biosciences.
[19] A. Nizam,et al. Containing pandemic influenza with antiviral agents. , 2004, American journal of epidemiology.
[20] A. Nizam,et al. Containing Pandemic Influenza at the Source , 2005, Science.
[21] A. Monto,et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. , 2006, The New England journal of medicine.
[22] W. Gruber,et al. Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections , 2006, The Pediatric infectious disease journal.
[23] D. Fleming,et al. Safety, Efficacy, and Effectiveness of Cold-Adapted Influenza Vaccine-Trivalent Against Community-Acquired, Culture-Confirmed Influenza in Young Children Attending Day Care , 2006, Pediatrics.
[24] M. Halloran,et al. Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004. , 2007, Vaccine.
[25] R. Walker,et al. Live attenuated versus inactivated influenza vaccine in infants and young children. , 2007, The New England journal of medicine.
[26] A. Razmpour,et al. Efficacy and Safety of a Live Attenuated, Cold-Adapted Influenza Vaccine, Trivalent Against Culture-Confirmed Influenza in Young Children in Asia , 2007, The Pediatric infectious disease journal.
[27] M. Halloran,et al. Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. , 2006, American journal of epidemiology.
[28] N. Ferguson,et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. , 2008, American journal of epidemiology.